Email Alert | RSS    帮助

中国防痨杂志 ›› 2013, Vol. 35 ›› Issue (12): 992-996.

• 论著 • 上一篇    下一篇

结核感染T细胞斑点试验在结核病诊断中的应用价值

王立红 付秀华 张桂芝 李国华 顾岩 高俊珍   

  1. 010050 呼和浩特,内蒙古医科大学附属医院呼吸内科(王立红、付秀华、李国华、顾岩、高俊珍); 内蒙古医科大学附属医院风湿免疫科(张桂芝)
  • 出版日期:2013-12-10 发布日期:2014-03-04
  • 通信作者: 付秀华 E-mail:fuxiuhua555@sohu.com

The value of T-SPOT.TB assay in the diagnosis of tuberculosis

WANG Li-hong, FU Xiu-hua, ZHANG Gui-zhi, LI Guo-hua, GU Yan, GAO Jun-zhen   

  1. Department of Respiration Medicine,the Affiliated Hospital of Inner Mongolian Medical University, Hohhot 010050, China
  • Online:2013-12-10 Published:2014-03-04
  • Contact: FU Xiu-hua E-mail:fuxiuhua555@sohu.com

摘要: 目的 评价结核感染T细胞斑点试验(T-SPOT.TB)在结核病诊断及鉴别结核病是否为活动性方面的价值。 方法 回顾性分析2011年7月至2012年4月内蒙古医科大学附属医院587例住院患者(结核性疾病患者128例,其中活动性结核组103例,陈旧性结核组25例;非结核性疾病患者459例,免疫损害组241例,非免疫损害组218例)的年龄、性别、病程、临床表现、T-SPOT.TB、病理、PPD、抗酸杆菌涂片及Mtb-Ab等的结果,数据采用SPSS 16.0 软件处理,计量资料比较采用Wilcoxon秩和检验,计数资料采用卡方检验,以P<0.05为差异有统计学意义。 结果 187例T-SPOT.TB阳性者中确诊结核病患者106例,阳性预测值56.68%(106/187),400例阴性者中确诊非结核病患者378例,阴性预测值 94.50%(378/400)。587例中共确诊结核性疾病128例,T-SPOT.TB检测的敏感度为82.81%(106/128),均高于结核菌素纯蛋白衍化物(PPD)35.71%(30/84)、抗酸杆菌涂片8.74%(9/103)及结核抗体(Mtb-Ab)14.06%(9/64)的敏感度,活动性与陈旧性结核的检测敏感度分别为93.20%(96/103)和40.00% (10/25);459例非结核性疾病患者中免疫损害组与非免疫损害组T-SPOT.TB的检测特异度分别为71.37%(172/241)和94.50%(206/218)。结核性胸膜炎及腹膜炎患者T-SPOT.TB的敏感度为100.00%(37/37)。活动性结核与陈旧性结核病患者混合肽ESAT-6和CFP-10总SFCs计数中位数分别为502个/106 PBMCs和430个/106 PBMCs, 四分位数间距(P25, P75)分别为(217个/106 PBMCs,1287个/106 PBMCs)和(140个/106 PBMCs,1303个/106 PBMCs),两组间比较采用Wilcoxon秩和检验,差异无统计学意义(U=429.5,P=0.585)。肺结核与肺外结核患者混合肽ESAT-6和CFP-10总SFC中位数分别为456个/106 PBMCs和528个/106 PBMCs, 四分位数间距(P25, P75)分别为(264个/106 PBMCs,950个/106 PBMCs)和(186个/106 PBMCs,1244个/106 PBMCs),两组间差异无统计学意义(U=1083.0,P=0.871)。 结论 T-SPOT.TB在低风险人群中检测的特异度较好,而在有潜在结核分枝杆菌感染的高危人群中检测的特异度明显降低,在结核性浆膜腔积液中检测的敏感度较高,与PPD、抗酸杆菌涂片及Mtb-Ab相比,敏感度较高,但对鉴别是否为活动性结核病并不理想。

关键词: 结核/诊断, &, gamma, 干扰素释放试验

Abstract: Objective  To evaluate the value of T-SPOT.TB assay in the diagnosis of tuberculosis (TB). Methods  Five hundred and eighty-seven cases of hospitalized patients (128 TB cases including 103 cases with active TB and 25 cases with old TB; 459 non-TB cases including 241 cases with immune impairment and 218 cases without immune damage) from 2011 July to 2012 April in Affiliated Hospital of Inner Mongolia Medical University were analyzed retrospectively in their age, gender, course of disease, clinical manifestations, the results of T-SPOT.TB assay, pathological examination, purified protein derivative (PPD) skin test, acid-fast bacilli smear and anti-TB antibody. The data were analyzed with software SPSS 16.0. The measurement data were compared with Wilcoxon rank test, and the count data were analyzed using chi square test. P<0.05 was considered as significant difference.  Results  Of 187 T-SPOT.TB-positive cases, 106 cases were diagnosed as TB, the positive predictive value was 56.68% (106/187). Of 400 T-SPOT.TB-negative cases, 378 cases were diagnosed as non-TB diseases, the negative predictive value was 94.50% (378/400). Of 587 cases, 128 cases were diagnosed as TB, the sensitivity of T-SPOT.TB assay was 82.81% (106/128), which was higher than that of PPD (35.71%, 30/84), acid-fast bacilli smear (8.74%, 9/103) and anti-TB antibody (14.06%, 9/64). The sensitivities of T-SPOT.TB in active TB and old TB were 93.20% (96/103) and 40.00% (10/25), respectively. Of 459 cases with non-TB diseases, the specificities of T-SPOT.TB in immune impairment group and non immune damage group were 71.37% (172/241) and 94.50% (206/218). The sensitivity of T-SPOT.TB in tuberculous pleurisy and peritonitis was 100.00% (37/37). The median count of T cell spots in active TB and old TB were 502/106 PBMCs and 430/106 PBMCs, respectively, four quartile range (P25, P75) were 217/106 PBMCs, 1287/106 PBMCs and 140/106 PBMCs, 1303/106 PBMCs, respectively. There were no significant difference between the 2 groups using the Wilcoxon rank test (U=429.5, P=0.585). The median count of T cell spots in pulmonary TB and extrapulmonary TB were 456/106 PBMCs and 528/106 PBMCs, respectively, four quartile range (P25, P75) were 264/106 PBMCs, 950/106 PBMCs and 186/106 PBMCs, 1244/106 PBMCs, respectively. There were no significant difference between the 2 groups (U=1083.0, P=0.871).  Conclusion  T-SPOT.TB assay has higher specificity in the low-risk population, while lower specifi-city in the high-risk population with latent tuberculosis infection, higher sensitivity in the patients with tuberculous effusion of serous cavity compared with PPD, acid-fast bacilli smear and antibody. But it cannot identify active TB with inactive TB.

Key words: Tuberculosis/diagnosis, Interferon-gamma release tests